Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma 论文
2018OncoTargets and Therapy引用 280
Melanoma and MAPK PathwaysComputational Drug Discovery MethodsCytokine Signaling Pathways and Interactions